ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

Young Investigators Hold Their Own

September 28, 1979

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

Elizabeth Miller Will Be Named to Cancer Panel

June 17, 1977

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

March 26, 2004

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003